“Pothead” could one day get a whole new meaning. A new study suggests low doses of THC, the main psychoactive ingredient in ...

For decades, Alzheimer’s disease has been framed as a one‑way slide, a slow erasure of memory that medicine could at best ...

A global expert review has identified a shingles vaccine and two existing drugs as leading candidates for repurposing against ...

Scientists have uncovered promising clues that compounds found in Aloe vera could play a role in fighting Alzheimer’s disease ...

A mathematical model simulated patient outcomes when given caregiver support or an expensive Alzheimer’s drug to determine cost and health benefits.

A once-a-day pill that helps slow down the course of Alzheimer’s disease is a step closer to becoming a reality in a major ...

Experts see shift toward tailored cancer therapy model Lilly awaiting details of Novo's failed trial Some drug developers target multiple biomarkers Sign up here. Globally, over 55 million people have ...

Campaigners have blasted the move as a "major disappointment”.

Programs that match caregivers with patient navigators yield better outcomes than Alzheimer's drug – but combining the two ...

From Science.org. "T3D Therapeutics alleges that contract researchers delivered “medically impossible” results on its candidate drug. In 2023, the drug ...

Biogen Inc. (NASDAQ:BIIB) on Friday reported better-than-expected fourth-quarter earnings, with adjusted EPS of $1.99, ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A scientist looks at hypometabolic and hypoperfusion patterns at the single-subject level from a patient suffering ...